1-2 of 2
Anne Meibohm, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment With Romiplostim, a Thrombopoietin-Receptor Agonist, In Thrombocytopenic Patients With Low Or Intermediate-1 Risk Myelodysplastic Syndrome: Updated Follow-Up Results For Acute Myeloid Leukemia and Survival From a Randomized, Double-Blind, Placebo-Controlled Study

Hagop M. Kantarjian, MD, Ghulam J. Mufti, MD, PhD, Pierre Fenaux, MD, PhD, Mikkael A. Sekeres, MD, MS, Jeffrey Szer, MBBS, Uwe Platzbecker, MD, PhD, Andrea Kuendgen, MD, Gianluca Gaidano, Wieslaw Wiktor-Jedrzejczak, Anne Meibohm, PhD, Angela Lopez, Aristoteles Giagounidis, MD
Journal: Blood
Blood (2013) 122 (21): 1553.
https://doi.org/10.1182/blood.V122.21.1553.1553
Published: 2013
Journal Articles

Treatment with the Thrombopoietin (TPO)-Receptor Agonist Romiplostim in Thrombocytopenic Patients (Pts) with Low or Intermediate-1 (int-1) Risk Myelodysplastic Syndrome (MDS): Follow-up AML and Survival Results of a Randomized, Double-Blind, Placebo (PBO)-Controlled Study

Hagop M. Kantarjian, MD, Ghulam J. Mufti, MD, Pierre Fenaux, MD, PhD, Mikkael A. Sekeres, MD, MS, Jeffrey Szer, MBBS, Uwe Platzbecker, MD, Andrea Kuendgen, Gianluca Gaidano, MD, PhD, Wieslaw Wiktor-Jedrzejczak, MD, PhD, John M. Bennett, MD, Anne Meibohm, PhD, Allen S. Yang, MD, PhD, Aristoteles Giagounidis, MD
Journal: Blood
Blood (2012) 120 (21): 421.
https://doi.org/10.1182/blood.V120.21.421.421
Published: 2012